Literature DB >> 1532578

Bombesin stimulates the rapid activation of phospholipase A2-catalyzed phosphatidylcholine hydrolysis in Swiss 3T3 cells.

S Currie1, G L Smith, C A Crichton, C G Jackson, C Hallam, M J Wakelam.   

Abstract

In Swiss 3T3 fibroblasts bombesin stimulated the release of arachidonic acid in a time- and dose-dependent manner. Arachidonate levels were significantly elevated after only a 2-s stimulation with the agonist. Furthermore, by measuring the arachidonate content of cellular phospholipids after cell activation, it was shown that there was selective depletion from phosphatidylcholine over the same time course. The corresponding production of lysophosphatidylcholine suggested the involvement of a phosphatidylcholine-specific phospholipase A2. Initial arachidonic acid release was not dependent on the presence of extracellular calcium, not activated by treatment of the cells with thapsigargin, and was unaffected by down-regulation of protein kinase C activity, or by treatment of the cells with the protein kinase C inhibitor staurosporine. These data strongly suggest that occupation of the bombesin receptor is closely coupled to activation of phospholipase A2 which results in the rapid release of arachidonic acid from phosphatidylcholine.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1532578

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Rapid desensitization and resensitization of bombesin-stimulated phospholipase D activity in Swiss 3T3 cells.

Authors:  C P Briscoe; R Plevin; M J Wakelam
Journal:  Biochem J       Date:  1994-02-15       Impact factor: 3.857

2.  Dual pathways for carbamylcholine-stimulated arachidonic acid release in rat pancreatic acini.

Authors:  W Hou; Y Arita; J Morisset
Journal:  Endocrine       Date:  1996-08       Impact factor: 3.633

3.  Permissive stimulation of Ca(2+)-induced phospholipase A2 by an adenosine receptor agonist in a pertussis toxin-sensitive manner in FRTL-5 thyroid cells: a new 'cross-talk' mechanism in Ca2+ signalling.

Authors:  S Shimegi; F Okajima; Y Kondo
Journal:  Biochem J       Date:  1994-05-01       Impact factor: 3.857

4.  Inhibition of endosome fusion by phospholipase A2 (PLA2) inhibitors points to a role for PLA2 in endocytosis.

Authors:  L S Mayorga; M I Colombo; M Lennartz; E J Brown; K H Rahman; R Weiss; P J Lennon; P D Stahl
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

5.  Arachidonic acid mobilization in P388D1 macrophages is controlled by two distinct Ca(2+)-dependent phospholipase A2 enzymes.

Authors:  J Balsinde; S E Barbour; I D Bianco; E A Dennis
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

6.  Protein kinase C-mediated phospholipase A2 activation, platelet-activating factor generation and prostacyclin release in spontaneously beating rat cardiomyocytes.

Authors:  D J Church; S Braconi; M B Vallotton; U Lang
Journal:  Biochem J       Date:  1993-03-01       Impact factor: 3.857

7.  Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells.

Authors:  J Ghosh; C E Myers
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

8.  Comparative pharmacology of bombesin receptor subtype-3, nonpeptide agonist MK-5046, a universal peptide agonist, and peptide antagonist Bantag-1 for human bombesin receptors.

Authors:  Paola Moreno; Samuel A Mantey; Bernardo Nuche-Berenguer; Marc L Reitman; Nieves González; David H Coy; Robert T Jensen
Journal:  J Pharmacol Exp Ther       Date:  2013-07-26       Impact factor: 4.030

9.  Diversity of roles of protein kinase C alpha in the proliferation of Swiss 3T3 cells.

Authors:  J Florin-Christensen; M Florin-Christensen; E Meinardi; R Calle
Journal:  Biochem J       Date:  1996-04-15       Impact factor: 3.857

Review 10.  International Union of Pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states.

Authors:  R T Jensen; J F Battey; E R Spindel; R V Benya
Journal:  Pharmacol Rev       Date:  2007-11-30       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.